Medtronic announced today that it received FDA approval for its Mosaic Neo mitral bioprosthesis and began its U.S. launch.
Vena Medical, a Kitchener, Canada—based developer of direct intravascular imaging systems, announced completion of the firs ...
VIT inaugurates a Centre of Excellence in Medical Technology to enhance indigenous medical device manufacturing and research ...
In a significant stride toward advancing cardiac care, the department of cardiology at Father Muller Medical College Hospital (FMMCH) inaugurated two state-of-the-art technologies—Intravascular ...
In a landmark achievement for healthcare in coastal Karnataka, Yenepoya Medical College Hospital (YMCH) has successfully ...
Boston Scientific Corporation (NYSE:BSX) is included in our list of the best low-risk high-reward stocks. As part of the firm’s Q1 preview for medical technology and life science tools firms, Evercore ...
Illuminant—founded in 2021 to build “X-ray vision” for doctors—has raised an $8.4 million seed round, Fortune has exclusively ...
In a move that could directly impact the cost of heart treatment, the National Pharmaceutical Pricing Authority (NPPA) has announced revised ceiling prices for coronary stents, effective April ...
Artivion, an Atlanta-based medtech that focuses on cardiac and vascular surgery, received pre-market approval (PMA) for its aortic stent graft system. The FDA approval also triggered an option by ...
FDA approval was supported by the one-year results of the TRIOMPHE Investigational Device Exemption (IDE) Study evaluating the NEXUS® System shown to effectively treat aortic arch disease, including ...
Alcon, in partnership with TrueVision 3D Surgical, has launched NGENUITY 3D, a complete digital solution for vitreoretinal surgery that uses an ultra-fast high-definition digital camera to provide an ...
Coronary artery disease (CAD) remains one of the leading causes of mortality and morbidity worldwide. Despite landmark progress in prevention, diagnosis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results